- Home
- PINS vs AXSM Comparison
PINS vs AXSM Comparison
Compare PINS & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PINS | AXSM |
|---|---|---|
| Founded | 2008 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6B | 10.4B |
| IPO Year | 2019 | 2015 |
Fundamental Metrics
Financial Performance| Metric | PINS | AXSM |
|---|---|---|
| Price | $18.45 | $208.94 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 29 | 17 |
| Target Price | $26.78 | ★ $211.12 |
| AVG Volume (30 Days) | ★ 10.0M | 515.5K |
| Earning Date | 05-04-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 38.56 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $4,221,767,000.00 | N/A |
| Revenue This Year | $14.48 | $57.24 |
| Revenue Next Year | $12.04 | $55.88 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 15.79 | N/A |
| 52 Week Low | $13.84 | $114.91 |
| 52 Week High | $36.15 | $260.19 |
Technical Indicators
Market Signals| Indicator | PINS | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 31.40 | 47.63 |
| Support Level | $17.75 | $206.94 |
| Resistance Level | $19.61 | $225.16 |
| Average True Range (ATR) | 0.79 | 7.51 |
| MACD | -0.22 | 1.16 |
| Stochastic Oscillator | 8.53 | 38.41 |
Price Performance
Historical ComparisonAbout PINS Pinterest Inc.
Pinterest is a social media platform with a focus on product and idea discovery. Pinterest users, or pinners, can leverage the platform as they go about gathering ideas on topics such as home improvement, fashion, cooking, and travel. The company has more than 500 million monthly active users, two thirds of whom are female. Pinterest generates revenue by selling digital ads on its platform. While the platform's user base spans the globe, the vast majority of its revenue stems from ads shown to North American users.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.